Diadem Dx diademdx.com |
Diadem is a clinical stage Italian in-vitro diagnostic start-up founded in 2012 that has developed a novel blood-based test exploiting a proprietary biomarker specific for prognosis and diagnosis of several forms of dementia, including Alzheimer’s Disease.
Diadem’s biomarker has been validated in several clinical longitudinal studies providing a strong signal in mixed pre-symptomatic and prodromal populations.
Aiming at solving one of the biggest medical needs in the fight against Alzheimer’s disease, supporting drug development and patient care: early, accurate, predictive, fast, non-invasive and cost-effective diagnosis.
Daniela Uberti
Founder
Paul Kinnon
CEO
Panakès board member